Cargando…
Identification of Potential Drug Targets for Antiplatelet Therapy Specifically Targeting Platelets of Old Individuals through Proteomic Analysis
Aging is a growing problem worldwide, and the prevalence and mortality of arterial and venous thromboembolism (VTE) are higher in the elderly than in the young population. To address this issue, various anticoagulants have been used. However, no evidence can confirm that antithrombotic agents are su...
Autores principales: | Lee, Seung Hee, Cho, Suyeon, Lee, Jong Youl, Hong, Jung Yeon, Kim, Suji, Jeong, Myong-Ho, Kim, Won-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669211/ https://www.ncbi.nlm.nih.gov/pubmed/38001945 http://dx.doi.org/10.3390/biomedicines11112944 |
Ejemplares similares
-
Change of Platelet Reactivity to Antiplatelet Therapy after Stenting Procedure for Cerebral Artery Stenosis: VerifyNow Antiplatelet Assay before and after Stenting
por: Lee, Deok Hee, et al.
Publicado: (2012) -
Variability of Platelet Reactivity on Antiplatelet Therapy in Neurointervention Procedure
por: Yi, Ho Jun, et al.
Publicado: (2019) -
Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?
por: Taus, Francesco, et al.
Publicado: (2019) -
The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease
por: Kim, Hyun Jung, et al.
Publicado: (2017) -
Long-Term Safety and Efficacy of Prolonged Dual Antiplatelet Therapy according to Baseline Anemia after Percutaneous Coronary Intervention
por: Kim, Hun-Tae, et al.
Publicado: (2022)